w-AMD
Conditions
Interventions
Case series:compassip
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
45 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Sign informed consent and be willing to provide visitation data in accordance with the data collection content specified in the test; 2. The target eye must meet the following requirements:Active choroidal neovascularization (CNV) lesions secondary to primary or recurrent central fovea and paracentricular fovea in w-amd,The criteria for judging active CNV are as follows: (1) Fresh bleeding; (2) Neuroepithelial detachment on OCT; (3) Leaking on fluorescein; 3. It can be photographed by color under the eye, fundus autofluorescence(FAF), OCT and FFA can be used to observe fundus; 4. best corrected visual acuity(BCVA) more than 20 letters(contains 20 letters); 5. Treatment expenses can be included in sichuan medical insurance catalog reimbursement.
Exclusion criteria
Exclusion criteria: 1. The investigator determined that the existing or previous non exudability AMD disease in the target eye seriously affected the detection of fundus or central vision, and best corrected visual acuity (BCVA) was less than 20 letters; 2. The target eye received PDT treatment within 6 months prior to screening or the target eye received medication for CNV within 6 months prior to screening (such as Ranibizumab, Bevacizumab injection, TA, Steroid etc.), or non target eyes were treated with VEGF drugs within 1 months before screening; 3. The target eye has received intraocular surgery within 3 months(retinal photocoagulation etc.), an eye operation had been received within 1 months(such as Eyelid surgery, pterygium surgery etc.); 4. Active eye infection of the target eye or the contralateral eye(such as Blepharitis, infectious conjunctivitis, keratitis, sclera, endophthalmitis); 5. Have a history of anaphylaxis or allergies to fluorescein sodium and ICG, and have a history of treating or diagnosing protein product.Have a history of allergies to treatment or diagnosis of protein products; 6. The target eye cannot complete two consecutive visits within 6 months; 7. The investigators say the need to exclude.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| best corrected visual acuity; | — |
Countries
China
Contacts
Public ContactMing Zhang
West China Hospital, Sichuan University
Outcome results
None listed